Clinical Trial Update: Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating combination chemotherapy with nelarabine for T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma | Phase 2 | Status: RECRUITING